Cerebral autoregulation in Alzheimer's disease

Jurgen A H R Claassen, Rong Zhang

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Cerebral autoregulation aims to stabilize blood flow to the brain during variations in perfusion pressure, thus protecting the brain against the risks of low or high systemic blood pressure. This vital mechanism is severely impaired in the transgenic mouse model of Alzheimer's disease (AD) that abundantly produces amyloid-Β peptide Β 1-42. These observations have been extrapolated to human AD, wherein impairment of autoregulation could have important implications for the clinical management and prevention of AD. Research on cerebral autoregulation in human AD, however, has only recently become available. Contrary to the animal models, preliminary studies suggest that cerebral autoregulation is preserved in patients with AD. Further research is urgently needed to elucidate this discrepancy in the current literature, given the accumulating evidence that implicates cerebrovascular pathology in AD.

Original languageEnglish (US)
Pages (from-to)1572-1577
Number of pages6
JournalJournal of Cerebral Blood Flow and Metabolism
Volume31
Issue number7
DOIs
StatePublished - Jul 2011

Fingerprint

Alzheimer Disease
Homeostasis
Brain
Research
Amyloid
Transgenic Mice
Animal Models
Perfusion
Pathology
Hypertension
Pressure
Peptides

Keywords

  • cerebral blood flow measurement
  • dementia
  • hypertension
  • infared spectroscopy
  • positron emission tomography
  • transcranial Doppler

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Clinical Neurology
  • Neurology

Cite this

Cerebral autoregulation in Alzheimer's disease. / Claassen, Jurgen A H R; Zhang, Rong.

In: Journal of Cerebral Blood Flow and Metabolism, Vol. 31, No. 7, 07.2011, p. 1572-1577.

Research output: Contribution to journalArticle

Claassen, Jurgen A H R ; Zhang, Rong. / Cerebral autoregulation in Alzheimer's disease. In: Journal of Cerebral Blood Flow and Metabolism. 2011 ; Vol. 31, No. 7. pp. 1572-1577.
@article{8d7002c06c2548e094db3a3d71bdcae2,
title = "Cerebral autoregulation in Alzheimer's disease",
abstract = "Cerebral autoregulation aims to stabilize blood flow to the brain during variations in perfusion pressure, thus protecting the brain against the risks of low or high systemic blood pressure. This vital mechanism is severely impaired in the transgenic mouse model of Alzheimer's disease (AD) that abundantly produces amyloid-Β peptide Β 1-42. These observations have been extrapolated to human AD, wherein impairment of autoregulation could have important implications for the clinical management and prevention of AD. Research on cerebral autoregulation in human AD, however, has only recently become available. Contrary to the animal models, preliminary studies suggest that cerebral autoregulation is preserved in patients with AD. Further research is urgently needed to elucidate this discrepancy in the current literature, given the accumulating evidence that implicates cerebrovascular pathology in AD.",
keywords = "cerebral blood flow measurement, dementia, hypertension, infared spectroscopy, positron emission tomography, transcranial Doppler",
author = "Claassen, {Jurgen A H R} and Rong Zhang",
year = "2011",
month = "7",
doi = "10.1038/jcbfm.2011.69",
language = "English (US)",
volume = "31",
pages = "1572--1577",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Cerebral autoregulation in Alzheimer's disease

AU - Claassen, Jurgen A H R

AU - Zhang, Rong

PY - 2011/7

Y1 - 2011/7

N2 - Cerebral autoregulation aims to stabilize blood flow to the brain during variations in perfusion pressure, thus protecting the brain against the risks of low or high systemic blood pressure. This vital mechanism is severely impaired in the transgenic mouse model of Alzheimer's disease (AD) that abundantly produces amyloid-Β peptide Β 1-42. These observations have been extrapolated to human AD, wherein impairment of autoregulation could have important implications for the clinical management and prevention of AD. Research on cerebral autoregulation in human AD, however, has only recently become available. Contrary to the animal models, preliminary studies suggest that cerebral autoregulation is preserved in patients with AD. Further research is urgently needed to elucidate this discrepancy in the current literature, given the accumulating evidence that implicates cerebrovascular pathology in AD.

AB - Cerebral autoregulation aims to stabilize blood flow to the brain during variations in perfusion pressure, thus protecting the brain against the risks of low or high systemic blood pressure. This vital mechanism is severely impaired in the transgenic mouse model of Alzheimer's disease (AD) that abundantly produces amyloid-Β peptide Β 1-42. These observations have been extrapolated to human AD, wherein impairment of autoregulation could have important implications for the clinical management and prevention of AD. Research on cerebral autoregulation in human AD, however, has only recently become available. Contrary to the animal models, preliminary studies suggest that cerebral autoregulation is preserved in patients with AD. Further research is urgently needed to elucidate this discrepancy in the current literature, given the accumulating evidence that implicates cerebrovascular pathology in AD.

KW - cerebral blood flow measurement

KW - dementia

KW - hypertension

KW - infared spectroscopy

KW - positron emission tomography

KW - transcranial Doppler

UR - http://www.scopus.com/inward/record.url?scp=79959835757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959835757&partnerID=8YFLogxK

U2 - 10.1038/jcbfm.2011.69

DO - 10.1038/jcbfm.2011.69

M3 - Article

VL - 31

SP - 1572

EP - 1577

JO - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

IS - 7

ER -